|
Reference Page
Malignant
Hyperthermia: What We Have Learned
Luis
M. Zabala, M.D.; Pediatric Cardiothoraic
Anesthesiologist, Arkansas Children’s Hospital;
Assistant Professor of Anesthesiology, Section of Pediatric
Cardiac Anesthesiology, University of Arkansas for Medical
Sciences.
1 – Denborough MA, Foster JF, Lovell
RR, et al. Anaesthetic deaths in a family. Brit J. Anaesth.
34:395-6, 1962.
2 – Malignant Hyperthermia Association
of the United States. – www.mhaus.org
3 – Jurkat-Rott K, McCarthy T, Lehmann-Horn F. Genetics
and pathogenesis of malignant hyperthermia. Muscle Nerve
23(1):4-17, 2000.
4 – Claxton BA, Cross MH, Hopkins P.
No response to trigger agents in malignant hyperthermia susceptible
patient. Br J. Anaesth. 88: 870, 2002.
5 – Litman RS, Rosenberg H. Malignant hyperthermia:
update on susceptibility testing. JAMA. 293(23):2918-24,
2005.
Other suggested literature:
- Fuhrman B, Zimmerman J. Pediatric Critical Care.
Third Edition. 2006. Chapter 117. Page 1780- 92.

|